CJC-1295 no DAC + Ipamorelin
Public supplier report and marketplace listing from Sulan Bio.
Supplier testing information
Independently quantified peptide blend
Sulan Bio CJC-1295 no DAC + Ipamorelin batch SUL0330-001 was independently analysed by Janoshik Laboratory under task #150932.
The analytical report recorded 5.24mg CJC-1295 no DAC (MOD GRF 1-29) and 5.21mg Ipamorelin in the submitted sample, providing component-specific quantitative documentation for this marketplace listing.
The two measured components provide a combined measured peptide content of 10.45mg compared with the nominal 5mg + 5mg configuration.
What is CJC-1295 no DAC + Ipamorelin?
This research blend combines CJC-1295 no DAC (MOD GRF 1-29) with Ipamorelin. The two peptides are of research interest because they interact with different receptor systems involved in growth hormone secretory signalling.
CJC-1295 no DAC is a synthetic growth hormone-releasing hormone (GHRH) analogue studied for its interaction with the GHRH receptor and its relationship with pulsatile growth hormone signalling.
Ipamorelin is a growth hormone secretagogue studied primarily for its activity at the growth hormone secretagogue receptor (GHSR), also known as the ghrelin receptor.
Common research areas
CJC-1295 no DAC and Ipamorelin are commonly investigated in laboratory and endocrine research examining:
- GHRH receptor signalling
- GHSR / ghrelin receptor signalling
- Growth hormone release and regulation
- Pulsatile growth hormone secretory pathways
- Pituitary signalling mechanisms
- GH/IGF-1 axis activity
- Endocrine signalling and regulation
- Interactions between distinct growth hormone secretagogue pathways
Two distinct signalling pathways
A key area of research interest in this blend is that its two components interact with different receptor systems. CJC-1295 no DAC is associated with GHRH receptor signalling, while Ipamorelin is associated with GHSR / ghrelin receptor signalling.
This makes the combination relevant to experimental models examining how separate upstream signalling pathways interact in the regulation of pituitary growth hormone release and downstream GH/IGF-1 signalling.
About CJC-1295 no DAC
CJC-1295 no DAC, commonly referred to as MOD GRF 1-29, does not contain the Drug Affinity Complex associated with longer-acting CJC-1295 variants.
Its comparatively short-lived signalling profile makes it of particular interest in laboratory research examining pulsatile GHRH receptor activation and growth hormone secretory mechanisms.
Available configuration
- CJC-1295 no DAC: nominal 5mg per vial
- Ipamorelin: nominal 5mg per vial
- Total nominal peptide content: 10mg per vial
- Box configuration: 10 vials
- MOQ: 10 vials / 1 box
- Format: Lyophilized research peptide blend
- Supplier: Sulan Bio
Batch verification
- Supplier: Sulan Bio
- Batch: SUL0330-001
- Nominal blend: 5mg CJC-1295 no DAC + 5mg Ipamorelin
- Measured CJC-1295 no DAC: 5.24mg
- Measured Ipamorelin: 5.21mg
- Measured combined content: 10.45mg
- Independent laboratory: Janoshik
- Task number: #150932
- Tested: 22 APR 2026
- COA status: Quantitative analysis available
This product is supplied strictly for laboratory research and analytical applications. It is not intended for human consumption, medical use, diagnostic use or clinical application.
CJC-1295 no DAC + Ipamorelin laboratory testing questions
What is this CJC-1295 no DAC + Ipamorelin report?
This report contains publicly accessible batch testing information for CJC-1295 no DAC + Ipamorelin, including task number #150932, reported purity results, and Janoshik-linked laboratory reference data.
Has this CJC-1295 no DAC + Ipamorelin batch been laboratory tested?
Yes. This CJC-1295 no DAC + Ipamorelin batch includes publicly accessible laboratory testing references, including reported purity result Blend Verified, task number #150932, and laboratory reference key KDCR99VHHH28.
Who supplied this CJC-1295 no DAC + Ipamorelin batch?
Sulan Bio supplied this CJC-1295 no DAC + Ipamorelin batch from China, with public batch testing references and tracked supplier fulfilment information.
What purity was reported for this CJC-1295 no DAC + Ipamorelin batch?
The reported purity result for this CJC-1295 no DAC + Ipamorelin batch was Blend Verified.
Where can I view additional CJC-1295 no DAC + Ipamorelin reports?
Additional CJC-1295 no DAC + Ipamorelin laboratory testing reports and supplier batch references can be viewed through the Buy China Peptides reports directory.